# Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

> **NCT02624765** · PHASE3 · COMPLETED · sponsor: **Edgar Jaeggi** · enrollment: 105 (actual)

## Conditions studied

- Fetal Atrial Flutter Without Hydrops
- Fetal Supraventricular Tachycardia Without Hydrops
- Fetal Supraventricular Tachycardia With Hydrops

## Interventions

- **DRUG:** Digoxin (monotherapy)
- **DRUG:** Sotalol (monotherapy)
- **DRUG:** Flecainide (monotherapy)
- **DRUG:** Digoxin (dual therapy)
- **DRUG:** Sotalol (dual therapy)
- **DRUG:** Flecainide (dual therapy)

## Key facts

- **NCT ID:** NCT02624765
- **Lead sponsor:** Edgar Jaeggi
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2024-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624765, "Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02624765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*